Literature DB >> 12184283

Efficacy of a low dose of thalidomide in advanced multiple myeloma.

Xavier Leleu, Leonardo Magro, Abir Fawaz, Francis Bauters, Tierry Facon, Ibrahim Yakoub-Agha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12184283     DOI： 10.1182/blood-2002-05-1527

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Transport of thalidomide by the human intestinal caco-2 monolayers.

Authors:  Shufeng Zhou; Yan Li; Phillip Kestell; Peter Schafer; Eli Chan; James W Paxton
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

2.  An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma.

Authors:  I Hus; A Dmoszynska; J Manko; M Hus; D Jawniak; M Soroka-Wojtaszko; A Hellmann; H Ciepluch; A Skotnicki; T Wolska-Smolen; K Sulek; T Robak; L Konopka; J Kloczko
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.